30. PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia.

Kelemen Á, Sebestyén E, Jakab Z, Matolcsy A, Kiss C, Kovács G, Savola S, Bödör C, Alpár D.
Journal/Proc./Book: British Journal of Cancer
Year: 2023
Thematic Pillar: Genomic Instability and Cancer

29. Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.

Timár B, Csomor J, Tóth E, Schneider T, Mikala G, Matolcsy A, Alpár D, Masszi A, Bödör C.
Journal/Proc./Book: Journal of Internal Medicine
Year: 2023
Thematic Pillar: Genomic Instability and Cancer

28. Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort.

Pipek O, Alpár D, Rusz O, Bödör C, Udvarnoki Z, Medgyes-Horváth A, Csabai I, Szállási Z, Madaras L, Kahán Z, Cserni G, Kővári B, Kulka J, Tőkés AM.
Journal/Proc./Book: International Journal of Molecular Sciences
Year: 2023
Thematic Pillar: Genomic Instability and Cancer

27. Liquid biopsy-based monitoring of residual disease in multiple myeloma by analysis of the rearranged immunoglobulin genes-A feasibility study.

Marx A, Osváth M, Szikora B, Pipek O, Csabai I, Nagy Á, Bödör C, Matula Z, Nagy G, Bors A, Uher F, Mikala G, Vályi-Nagy I, Kacskovics I.
Journal/Proc./Book: PLoS One
Year: 2023
Thematic Pillar: Genomic Instability and Cancer

26. Next-Generation Sequencing-Based Genomic Profiling of Children with Acute Myeloid Leukemia.

Krizsán S, Péterffy B, Egyed B, Nagy T, Sebestyén E, Hegyi LL, Jakab Z, Erdélyi DJ, Müller J, Péter G, Csanádi K, Kállay K, Kriván G, Barna G, Bedics G, Haltrich I, Ottóffy G, Csernus K, Vojcek Á, Tiszlavicz LG, Gábor KM, Kelemen Á, Hauser P, Gaál Z, Szegedi I, Ujfalusi A, Kajtár B, Kiss C, Matolcsy A, Tímár B, Kovács G, Alpár D, Bödör C.
Journal/Proc./Book: Journal of Molecular Diagnostics
Year: 2023
Thematic Pillar: Genomic Instability and Cancer

25. Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.

Kotmayer L, László T, Mikala G, Kiss R, Lévay L, Hegyi LL, Gróf S, Nagy T, Barna G, Farkas P, Weisinger J, Nagy Z, Balogh A, Masszi T, Demeter J, Sulák A, Kohl Z, Alizadeh H, Egyed M, Pettendi P, Gergely L, Plander M, Pauker Z, Masszi A, Matolcsy A, Szász R, Bödör C, Alpár D.
Journal/Proc./Book: International Journal of Molecular Sciences
Year: 2023
Thematic Pillar: Genomic Instability and Cancer

24. Case report: Complete and durable response to larotrectinib (TRK inhibitor) in an infant diagnosed with angiosarcoma harbouring a KHDRBS1-NTRK3 fusion gene.

Cervi C, Sápi Z, Bedics G, Zajta E, Hegyi L, Pápay J, Dezső K, Varga E, Mudra K, Bödör C, Csóka M.
Journal/Proc./Book: Frontiers in Oncology
Year: 2023
Thematic Pillar: Genomic Instability and Cancer

23. Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes.

Casado P, Rio-Machin A, Miettinen JJ, Bewicke-Copley F, Rouault-Pierre K, Krizsan S, Parsons A, Rajeeve V, Miraki-Moud F, Taussig DC, Bödör C, Gribben J, Heckman C, Fitzgibbon J, Cutillas PR.
Journal/Proc./Book: Signal Transduction and Targeted Therapy
Year:  2023
Thematic Pillar: Genomic Instability and Cancer

22. Epigenome profiling reveals aberrant DNA methylation signature in GATA2 deficiency.

Marin-Bejar O, Romero-Moya D, Rodriguez-Ubreva J, Distefano M, Lessi F, Aretini P, Liquori A, Castaño J, Kozyra E, Kotmayer L, Bueno C, Cervera J, Rodriguez-Gallego JC, Nomdedeu JF, Murillo-Sanjuán L, De Heredia CD, Pérez-Martinez A, López-Cadenas F, Martínez-Laperche C, Dorado-Herrero N, Marco FM, Prósper F, Menendez P, Valcárcel D, Ballestar E, Bödör C, Bigas A, Catalá A, Wlodarski MW, Giorgetti A.
Journal/Proc./Book: Acta Haematologica
Year:  2023
Thematic Pillar: Genomic Instability and Cancer

21. BTK and PLCG2 remain unmutated in one third of patients with CLL relapsing on ibrutinib.

Bonfiglio S, Sutton LA, Ljungström V, Capasso A, Pandzic T, Weström S, Foroughi-Asl H, Skaftason A, Gellerbring A, Lyander A, Gandini F, Gaidano G, Trentin L, Bonello L, Reda G, Bödör C, Stavroyianni N, Tam CS, Marasca R, Forconi F, Panayiotidis P, Ringshausen I, Jaksic O, Frustaci AM, Iyengar S, Coscia M, Mulligan SP, Ysebaert L, Strugov V, Pavlovsky C, Walewska R, Österborg A, Cortese D, Ranghetti P, Baliakas P, Stamatopoulos K, Scarfò L, Rosenquist R, Ghia P.

Journal/Proc./Book: Blood advances
Year:  2023
Thematic Pillar: Genomic Instability and Cancer

20. Protein Kinase D3 (PKD3) Requires Hsp90 for Stability and Promotion of Prostate Cancer Cell Migration.

Varga A, Nguyen MT, Pénzes K, Bátai B, Gyulavári P, Gurbi B, Murányi J, Csermely P, Csala M, Vántus T, Sőti C.

Journal/Proc./Book: Cells
Year:  2023
Thematic Pillar: Genomic Instability and Cancer

19. MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia.

Rzepiel A, Horváth A, Kutszegi N, Gézsi A, Sági JC, Almási L, Egyed B, Lőrincz P, Visnovitz T, Kovács GT, Szalai C, Semsei ÁF, Erdélyi DJ.

Journal/Proc./Book: Molecular and Cellular Probes
Year:  2023
Thematic Pillar: Genomic Instability and Cancer

18. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D, Catherwood M, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A, Rani L, Baliakas P, Foroughi-Asl H, Jylhä C, Skaftason A, Rapado I, Miras F, Martinez-Lopez J, de la Serna J, Rivas JMH, Thornton P, Larráyoz MJ, Calasanz MJ, Fésüs V, Mátrai Z, Bödör C, Smedby KE, Espinet B, Puiggros A, Gupta R, Bullinger L, Bosch F, Tazón-Vega B, Baran-Marszak F, Oscier D, N’Guyen-Khac F, Zenz T, Terol MJ, Cuneo A, Hernández-Sánchez M, Pospisilova S, Mills K, Gaidano G, Niemann CU, Campo E, Strefford JC, Ghia P, Stamatopoulos K, Rosenquist R.
Journal/Proc./Book: Leukemia
Year: 2022
Thematic Pillar: Genomic Instability and Cancer

17. Novel actionable ROS1::GIT2 fusion in non-Langerhans cell histiocytosis with central nervous system involvement.

Bedics G, Csóka M, Reiniger L, Varga E, Liptai Z, Papp G, Bekő A, Cervi C, Bödör C, Scheich B.
Journal/Proc./Book: Acta neuropathologica communications
Year: 2022
Thematic Pillar: Genomic Instability and Cancer

16. Myelofibrosis progression grading based on type-I and type-III collagen and fibrillin-1 expression boosted by whole slide image analysis.

Szekely T, Wichmann B, Maros ME, Csizmadia A, Bodor C, Timar B, Krenacs T.
Journal/Proc./Book: Histopathology
Year: 2022
Thematic Pillar: Genomic Instability and Cancer

15. Potential role of MAP2K1 mutation in the trans-differentiation of interdigitating dendritic cell sarcoma: Case report and literature review.

Jenei A, Bedics G, Erdélyi DJ, Müller J, Györke T, Bödör C, Szepesi Á.
Journal/Proc./Book: Frontiers in Pediatrics
Year: 2022
Thematic Pillar: Genomic Instability and Cancer

14. IBCL-222 Parallel Testing of Liquid Biopsy (ctDNA) and Tissue Biopsy Samples Yields Higher Frequency of EZH2 Mutations in Follicular Lymphoma.

Nagy Á, Bátai B, Gróf S, Kiss L, Balogh A, Mikala G, Király PA, Jóna Á, Demeter J, Masszi T, Masszi A, Schneider T, Bödör C.
Journal/Proc./Book: Clin Lymphoma Myeloma Leuk.
Year: 2022
Thematic Pillar: Genomic Instability and Cancer

13. A High-Throughput Clinical Laboratory Methodology for the Therapeutic Monitoring of Ibrutinib and Dihydrodiol Ibrutinib.

Karvaly GB, Vincze I, Balogh A, Köllő Z, Bödör C, Vásárhelyi B.
Journal/Proc./Book: Molecules
Year: 2022
Thematic Pillar: Genomic Instability and Cancer

12. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.

Kotmayer L, Romero-Moya D, Marin-Bejar O, Kozyra E, Català A, Bigas A, Wlodarski MW, Bödör C, Giorgetti A.
Journal/Proc./Book: British Journal of Haematology
Year: 2022
Thematic Pillar: Genomic Instability and Cancer

11. The EHA Research Roadmap: Malignant Lymphoid Diseases.

Dreyling M, André M, Gökbuget N, Tilly H, Jerkeman M, Gribben J, Ferreri A, Morel P, Stilgenbauer S, Fox C, Maria Ribera J, Zweegman S, Aurer I, Bödör C, Burkhardt B, Buske C, Dollores Caballero M, Campo E, Chapuy B, Davies A, de Leval L, Doorduijn J, Federico M, Gaulard P, Gay F, Ghia P, Grønbæk K, Goldschmidt H, Kersten MJ, Kiesewetter B, Landman-Parker J, Le Gouill S, Lenz G, Leppä S, Lopez-Guillermo A, Macintyre E, Mantega MVM, Moreau P, Moreno C, Nadel B, Okosun J, Owen R, Pospisilova S, Pott C, Robak T, Spina M, Stamatopoulos K, Stary J, Tarte K, Tedeschi A, Thieblemont C, Trappe RU, Trümper LH, Salles G.

Journal/Proc./Book:HemaSphere
Year: 2022
Thematic Pillar: Genomic Instability and Cancer

10. Case Report: Development of Diffuse Large B Cell Lymphoma a Long Time After Hairy Cell Leukemia

Veres T, Voniatis C, Molnár K, Nesztor D, Fehér D, Ferencz A, Gresits I, Thuróczy G, Márkus BG, Simon F, Nemes NM, García-Hernández M, Reiniger L, Horváth I, Máthé D, Szigeti K, Tombácz E, Jedlovszky-Hajdu A.
Journal/Proc./Book: Pathology&Oncology Research
Year: 2022
Thematic Pillar: Genomic Instability and Cancer

9. Germline MUTYH mutations and high-grade gliomas: novel evidence for a potential association

Bedics G, Kotmayer L, Zajta E, Hegyi LL, Brückner EÁ, Rajnai H, Reiniger L, Bödör C, Garami M, Scheich B.
Journal/Proc./Book: Genes Chromosomes and Cancer
Year: 2022
Thematic Pillar: Genomic Instability and Cancer

8. Correlations Between the Expression of Stromal Cell Activation Related Biomarkers, L-NGFR, Phospho-ERK1-2 and CXCL12, and Primary Myelofibrosis Progression.

Szekely T, Krenacs T, Maros ME, Bodor C, Daubner V, Csizmadia A, Vrabely B, Timar B.
Journal/Proc./Book: Pathology&Oncology Research
Year: 2022
Thematic Pillar: Genomic Instability and Cancer

7. Acquired somatic variants in inherited myeloid malignancies.

Armes H, Rio-Machin A, Krizsán S, Bödör C, Kaya F, Bewicke-Copley F, Alnajar J, Walne A, Péterffy B, Tummala H, Rouault-Pierre K, Dokal I, Vulliamy T, Fitzgibbon J.
Journal/Proc./Book: Leukemia
Year: 2022
Thematic Pillar: Genomic Instability and Cancer

6. Distinct miRNA Expression Signatures of Primary and Secondary Central Nervous System Lymphomas.

Sebestyén E, Nagy Á, Marosvári D, Rajnai H, Kajtár B, Deák B, Matolcsy A, Brandner S, Storhoff J, Chen N, Bagó AG, Bödör C, Reiniger L.
Journal/Proc./Book: The journal of molecular diagnostics
Year: 2021
Thematic Pillar: Genomic Instability and Cancer

5. Single-Cell Sequencing: Biological Insight and Potential Clinical Implications in Pediatric Leukemia

Donát Alpár, Bálint Egyed, Csaba Bödör, Gábor T. Kovács
Journal/Proc./Book: Cancers
Year: 2021
Thematic Pillar: Genomic Instability and Cancer

4. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

Wei-Yu Lin, Sarah E. Fordham, Eric Hungate, Nicola J. Sunter, Claire Elstob, Yaobo Xu, Catherine Park, Anne Quante, Konstantin Strauch, Christian Gieger, Andrew Skol, Thahira Rahman, Lara Sucheston-Campbell, Junke Wang, Theresa Hahn, Alyssa I. Clay-Gilmour, Gail L. Jones, Helen J. Marr, Graham H. Jackson, Tobias Menne, Mathew Collin, Adam Ivey, Robert K. Hills, Alan K. Burnett, Nigel H. Russell, Jude Fitzgibbon, Richard A. Larson, Michelle M. Le Beau, Wendy Stock, Olaf Heidenreich, Abrar Alharbi, David J. Allsup, Richard S. Houlston, Jean Norden, Anne M. Dickinson, Elisabeth Douglas, Clare Lendrem, Ann K. Daly, Louise Palm, Kim Piechocki, Sally Jeffries, Martin Bornhäuser, Christoph Röllig, Heidi Altmann, Leo Ruhnke, Desiree Kunadt, Lisa Wagenführ, Heather J. Cordell, Rebecca Darlay, Mette K. Andersen, Maria C. Fontana, Giovanni Martinelli, Giovani Marconi, Miguel A. Sanz, José Cervera, Inés Gómez-Seguí, Thomas Cluzeau, Chimène Moreilhon, Sophie Raynaud, Heinz Sill, Maria Teresa Voso, Francesco Lo-Coco, Hervé Dombret, Meyling Cheok, Claude Preudhomme, Rosemary E. Gale, David Linch, Julia Gaal-Wesinger, Andras Masszi, Daniel Nowak, Wolf-Karsten Hofmann, Amanda Gilkes, Kimmo Porkka, Jelena D. Milosevic Feenstra, Robert Kralovics, David Grimwade, Manja Meggendorfer, Torsten Haferlach, Szilvia Krizsán, Csaba Bödör, Friedrich Stölzel, Kenan Onel, James M. Allan
Journal/Proc./Book: Nature Communications
Year: 2021
Thematic Pillar: Genomic Instability and Cancer

3. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax

Ambrus Gángó, Richárd Kiss, Péter Farkas, Eid Hanna, Judit Demeter, Beáta Deák, Dóra Lévai, Lili Kotmayer, Donát Alpár, András Matolcsy, Csaba Bödör, Zoltán Mátrai, Botond Timár
Journal/Proc./Book: Pathology
Year: 2021
Thematic Pillar: Genomic Instability and Cancer

2. The RUNX1 Database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy

Claire C. Homan, Sarah L. King-Smith, David M. Lawrence, Peer Arts, Jinghua Feng, James Andrews, Mark Armstrong, Thuong Ha, Julia Dobbins, Michael W. Drazer, Kai Yu, Csaba Bödör, Alan Cantor, Mario Cazzola, Erin Degelman, Courtney D. DiNardo, Nicolas Duployez, Remi Favier, Stefan Fröhling, Jude Fitzgibbon, Jeffery M. Klco, Alwin Krämer, Mineo Kurokawa, Joanne Lee, Luca Malcovati, Neil V. Morgan, Georges Natsoulis, Carolyn Owen, Keyur P. Patel, Claude Preudhomme, Hana Raslova, Hugh Rienhoff, Tim Ripperger, Rachael Schulte, Kiran Tawana, Elvira Velloso, Benedict Yan, Paul Liu, Lucy A. Godley, Andreas W. Schreiber, Christopher N. Hahn, Hamish S. Scott, Anna L. Brown
Journal/Proc./Book: Haematologica
Year: 2021
Thematic Pillar: Genomic Instability and Cancer

1. Screening and monitoring of the BTK C481S mutation in a real‐world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy

Csaba Bödör, Lili Kotmayer, Tamás László, Ferenc Takács, Gábor Barna, Richárd Kiss, Endre Sebestyén, Tibor Nagy, Lajos László Hegyi, Gábor Mikala, Sándor Fekete, Péter Farkas, Alexandra Balogh, Tamás Masszi, Judit Demeter, Júlia Weisinger, Hussain Alizadeh, Béla Kajtár, Zoltán Kohl, Róbert Szász, Lajos Gergely, Timea Gurbity Pálfi, Adrienn Sulák, Balázs Kollár, Miklós Egyed, Márk Plander, László Rejtő, László Szerafin, Péter Ilonczai, Péter Tamáska, Piroska Pettendi, Dóra Lévai, Tamás Schneider, Anna Sebestyén, Péter Csermely, András Matolcsy, Zoltán Mátrai, Donát Alpár
Journal/Proc./Book: British Journal of Haematology
Year: 2021
Thematic Pillar: Genomic Instability and Cancer